| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2019/01/17 | 18:00 | PR Newswire (US) | Asceneuron Appoints Peter Van Vlasselaer as Chairman | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2019/01/17 | 18:00 | PR Newswire (US) | Asceneuron Appoints Peter Van Vlasselaer as Chairman | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/07/03 | 05:49 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/23 | 08:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/23 | 06:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/23 | 06:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/23 | 06:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/23 | 06:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/23 | 06:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/23 | 06:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/23 | 06:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/23 | 06:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/23 | 06:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/23 | 06:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/22 | 22:13 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/22 | 22:03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/22 | 21:59 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/22 | 21:54 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/22 | 21:48 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/22 | 21:31 | PR Newswire (US) | Lilly Completes Acquisition of ARMO BioSciences | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/19 | 06:06 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/16 | 06:04 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/16 | 05:27 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/06/11 | 21:31 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/05/31 | 06:05 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/05/31 | 06:03 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/05/23 | 22:18 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/05/23 | 21:49 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/05/16 | 05:52 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 2018/05/15 | 00:38 | PR Newswire (US) | WeissLaw LLP: ARMO BioSciences Inc. Acquisition May Not Be In The Best Interests of ARMO shareholders | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |